Your browser doesn't support javascript.
loading
Risk factors for COVID-19 mortality in hospitalized patients in Bolivia.
Limachi-Choque, Jhonny; Guitian, Javier; Leyns, Christine; Guzman-Rivero, Miguel; Eid, Daniel.
Afiliación
  • Limachi-Choque J; Centro Universitario de Medicina Tropical (CUMETROP), Faculty of Medicine, Universidad Mayor de San Simon, Cochabamba, Bolivia.
  • Guitian J; Unidad de Epidemiologia, Corporación del Seguro Social Militar (COSSMIL), Cochabamba, Bolivia.
  • Leyns C; Institute of Biomedical Research and Social Research, Faculty of Medicine, Universidad Mayor de San Simón, Cochabamba, Bolivia.
  • Guzman-Rivero M; The Royal Veterinary College, University of London, London, United Kingdom.
  • Eid D; Instituto de Investigaciones en Ciencias Sociales, Facultad de Ciencias Sociales, Universidad Mayor de San Simon, Cochabamba, Bolivia.
IJID Reg ; 9: 95-101, 2023 Dec.
Article en En | MEDLINE | ID: mdl-38020182
ABSTRACT

Objectives:

This study aimed to ascertain which factors are associated with higher risk of mortality among hospitalized COVID-19 Bolivian patients.

Methods:

This retrospective observational study assessed risk factors associated with mortality in patients (n = 549) hospitalized for SARS-CoV-2 infection in a Bolivian hospital between April 6, 2020, and August 18, 2022.

Results:

The results provide evidence of association between male sex (odds ratio [OR] = 1.6, 95% confidence interval [CI] 1.06-2.6), older age, 51-61 years-old (OR = 5.2, 95% CI 2.2-12.6), 62-70 years-old (OR = 8.7, 95% CI 3.7-20.5), >70 years-old (OR = 16.9, 95% CI 7.1-39.9), and blood group A (OR = 1.9, 95% CI 1.1-3.4) with higher mortality risk. The strong association between mortality and relatively young age, may be due to high frequency of undiagnosed comorbidities. Vaccination was associated with a reduction in mortality only when time period of hospitalization was not adjusted for.

Conclusion:

Among hospitalized patients in Bolivia male sex, older age, and blood group A are associated with higher mortality risk. Mortality risk increased markedly from a relatively young age and decreased in parallel to the uptake of the vaccination program. However, the gradual reduction in mortality can also be due to improved patient management and changes in natural immunity and virulence of circulating strains as the pandemic progressed.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE País/Región como asunto: America do sul / Bolivia Idioma: En Revista: IJID Reg Año: 2023 Tipo del documento: Article País de afiliación: Bolivia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE País/Región como asunto: America do sul / Bolivia Idioma: En Revista: IJID Reg Año: 2023 Tipo del documento: Article País de afiliación: Bolivia